INNT
TOTAL INVALIDATION PROCESSED BY THE IB
01/09/2022
Back to search
Official data from USPTO
QIAGEN SAMPLE & ASSAY TECHNOLOGIES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
QIAGEN SAMPLE & ASSAY TECHNOLOGIES
ST13
US500000079034146Class
1, 5, 9, 42
Filing
79034146
Registration
3423104
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
55
Latest update
01/09/2022
Trademark type
Word
Nice classes
1, 5, 9, 42
Filing date
10/10/2006
Registration date
05/06/2008
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/26/2021
Last transaction
02/26/2021
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
Hilden, DE
Examiner
SOBRAL, CHRISTINA
Law office
L90
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
QIAGEN GmbH
QIAGEN GmbH
Representatives
Roxana A. Sullivan Dennemeyer & Associates, LLC
Technical classification
Nice Classes
Class 1Class 5Class 9Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicalbiochemical and biotechnological products for industrial and scientific purposessample preparationpurificationlysismodification and manipulation of cells and markingseparationisolationpurificationamplification and analysis of biopolymersnucleic acids; enzymes containing carbon; DNA and RNA polymerases; reagents for staining and marking nucleic acidspeptides and proteins for genetic research; buffer chemicals used in chemistrybiologybiochemistry and biotechnology; aqueous and nonaqueous solutions of primarysecondary and tertiary alcohols and salts for lysis and binding of biological materials; distilled and purified water; silica powdergranulate and gel; magnetic particlesproteinsmacro molecules and biologically active substances for separationanalysis and purification of biological and biochemical compounds; materials for separation columns for separationanalysis and purification of biological and biochemical compounds; Chemicals and biochemicals for industrial and scientific purposesreagents and solvents for sample preparationpurificationlysismodification and manipulation of cells; Chemicals and biochemicals for industrial and scientific purposesreagents and solvents for markingseparationisolationpurificationamplification and analysis of biopolymers; Kits containing chemicalbiochemical and biotechnological products for industrial and scientific purposesfor sample preparationpurificationlysismodification and manipulation of cells and markingseparationisolationpurificationamplification and analysis of biopolymersnucleic acidsenzymes containing carbon; DNA and RNA polymerasesreagents for staining and marking acidspeptides and proteins for genetic researchbuffer chemicals used in chemistrybiologybiochemistry and biotechnologyaqueous or nonaqueous solutions of primarysecondary and tertiary alcohols and salts for lysis and binding of biological materialsdistilled and purified watersilica powdergranulate and gelmagnetic particlesproteinsmacro molecules and biologically active substances for separationanalysis and purification of biological or biochemical compoundsmaterials for separation columns for separationanalysis and purification of biological and biochemical compounds; Chemicals and biochemicals for industrial and scientific purposesreagents and solvents for sample preparationpurificationlysismodification and manipulation of cellsreagents and solvents for markingseparationisolationpurificationamplification and analysis of biopolymersall included in this class
Class 5
Diagnostic preparations for medical and veterinary medical purposes; diagnostic preparations for medical and veterinary medical purposes comprising any of nucleic acids; enzymes; polymerases; reagents for staining and marking; buffer chemicals; aqueous and nonaqueous solutions of primarysecondary and tertiary alcohols and salts; distilled and purified water; silica powdergranulate and gel; magnetic particles; materials for separation columns for separationanalysis and purification of biological and biochemical compounds; andkits containing all of the preceding named products for medical and veterinary medical purposesall included in this class
Class 9
Scientific apparatusinstruments and equipment for researchdevelopment and examination purposeslaboratory equipmentchromatography columnsrobots and automated laboratory equipment; spare parts and add-ons therefor; preprogrammed cards for DNA purification protocols; crystallization tubes; prefilled crystallization tubes; microplates and prefilled microplates; crystallization supports; pipettespipette tips and pipette tip holders; sample containers; reagent holders; flasks; reagent tube holders; holders for micro containers; magnetic particles and magnetic syringes; biochips; thermocyclers; homogenizers; vacuum valvesall included in this class
Class 42
Scientific researchdevelopment and diagnostics for others in the fields of chemistrygeneticsbiology and biochemistry; diagnostic services for others in the fields of DNARNA and protein detection and analysis; services in the field of forensicsanalysisdetection and isolation of biological substances in forensic samples; design for others in the fields of chemistrygeneticsbiology and biochemistryall included in this class
Publications
History of USPTO decisions and trademark events.
55 publications found
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
11/30/2021
INPC
INVALIDATION PROCESSED
11/30/2021
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
10/26/2021
C71T
CANCELLED SECTION 71
02/26/2021
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
05/06/2017
RNWL
INTERNATIONAL REGISTRATION RENEWED
10/27/2016
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
05/09/2014
C75A
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
05/09/2014
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/09/2014
715F
REGISTERED - SEC. 71 & SEC. 15 FILED
04/08/2014
ES75
TEAS SECTION 71 & 15 RECEIVED
04/08/2014
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/22/2012
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/14/2009
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/14/2009
FICS
FINAL DISPOSITION NOTICE SENT TO IB
08/25/2008
FIMP
FINAL DISPOSITION PROCESSED
08/25/2008
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/06/2008
R.PR
REGISTERED-PRINCIPAL REGISTER
05/06/2008
PUBO
PUBLISHED FOR OPPOSITION
02/19/2008
NPUB
NOTICE OF PUBLICATION
01/30/2008
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
01/14/2008
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/14/2008
XAEC
EXAMINER'S AMENDMENT ENTERED
01/14/2008
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/14/2008
GNEA
EXAMINERS AMENDMENT E-MAILED
01/14/2008
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/14/2008
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
01/10/2008
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
11/16/2007
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
11/05/2007
CORR
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
10/22/2007
ALIE
ASSIGNED TO LIE
10/16/2007
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
09/27/2007
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/16/2007
XAEC
EXAMINER'S AMENDMENT ENTERED
09/12/2007
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/12/2007
GNEA
EXAMINERS AMENDMENT E-MAILED
09/12/2007
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/12/2007
XAEC
EXAMINER'S AMENDMENT ENTERED
09/07/2007
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/07/2007
GNEA
EXAMINERS AMENDMENT E-MAILED
09/07/2007
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/07/2007
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/05/2007
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/05/2007
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/05/2007
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/18/2007
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/18/2007
RFNT
REFUSAL PROCESSED BY IB
03/23/2007
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/05/2007
RFRR
REFUSAL PROCESSED BY MPU
03/01/2007
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/01/2007
CNRT
NON-FINAL ACTION WRITTEN
02/28/2007
DOCK
ASSIGNED TO EXAMINER
02/26/2007
NWAP
NEW APPLICATION ENTERED
02/23/2007
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/22/2007
Continuous trademark protection
Get notified about every new filing that threatens QIAGEN SAMPLE & ASSAY TECHNOLOGIES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.